Clinical Trial Update: Gemcitabine and Carboplatin After Progression on Enfortumab Vedotin and Pembrolizumab in Advanced/Metastatic Urothelial Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating gemcitabine and carboplatin after progression on enfortumab vedotin and pembrolizumab in advanced/metastatic urothelial carcinoma; re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Drugs mentioned

• Gemzar (gemcitabine)
• KEYTRUDA (PEMBROLIZUMAB)
• Padcev (enfortumab vedotin)
• Paraplatin (Carboplatin)

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Urothelial Carcinoma | Phase 2 | Status: RECRUITING